The first CAR-T therapies are on the market, but the commercial journey is far from over.
This week's Fierce Drug Delivery is brought to you by Catalent. Trouble viewing? Click here.
|
| Tuesday, November 16, 2021 | 11am ET / 8am PT | |
|
|
| Manufacturing cell-based drugs is unlike anything most drug developers ever faced and requires specialized skills. Anyone with those skills is going to be in demand and expensive. One expert tip: Start your search for experienced people sooner than later. This webinar will discuss the challenges posed by this new wave of therapies and how the pioneers in the field are tackling them. |
---|
| |
|
|
| When your manufacturing process depends on healthcare professionals working with the patients to get the front-end and back-end of the processes exactly right, those professionals need to understand your process unequivocally. That may mean having a team of trainers to make that happen. |
---|
| |
|
|
| You are currently subscribed as [email protected] If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe. Refer to our Privacy Policy. Fierce LifeSciences is a division of Questex LLC. 685 3rd Ave 21st Floor New York, NY 10017 © 2021 Questex LLC. All Rights Reserved. Reproduction in whole or in part is prohibited without written permission. | |
|
|